Ask me later

Ask me later

How likely are you to recommend Redeye to a friend or colleague?

1

2

3

4

5

6

7

8

9

10

Not likely

Very likely

Not likely

1

2

3

4

5

6

7

8

9

10

Very likely

Message received

Thanks again for rating us!

Paxman: Game Changer on the Horizon

MH

Mats Hyttinge

Redeye initiates coverage of Paxman, a Swedish/English medical technology company. They develop, produce, and market their scalp cooling system that reduces hair loss (alopecia) associated with chemotherapy. We see an attractive case with significant upside potential. Strong clinical data and positive drivers for reimbursement in the US are the right ingredients for an exciting growth journey.

Disclosures and disclaimers